Lasa Supergenerics PAT at 12.35 Cr up by Robust 362 percent as Compared to Loss of 4.71 Cr in Q3FY22
Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the fourth quarter and Financial Year ended March ...